알파-D-글루코피라노스

White crystalline powder; Odorless; [Acros Organics MSDS]

Solid

146.2 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

146.6 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

146.5 Ų [M+Na]+；147.1 Ų [M+Na]+

This chemical does not meet GHS hazard criteria for 98% (48 of 49) of all reports.

Not Classified；Reported as not meeting GHS hazard criteria by 48 of 49 companies (only 2% companies provided GHS information). For more detailed information, please visit ECHA C&L website.

Aggregated GHS information provided per 49 reports by companies from 3 notifications to the ECHA C&L Inventory.；Reported as not meeting GHS hazard criteria per 48 of 49 reports by companies.；There is 1 notification provided by 1 of 49 reports by companies with hazard statement code(s).；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Chemical: .alpha.-D-Glucopyranose

.alpha.-D-Glucopyranose: Does not have an individual approval but may be used under an appropriate group standard

Chemical: .alpha.-D-Glucopyranose

.alpha.-D-Glucopyranose: Does not have an individual approval but may be used under an appropriate group standard

Fanconi-bickel syndrome；Fructose and mannose metabolism；Fructose intolerance, hereditary；Fructose-1,6-diphosphatase deficiency；Fructosuria；Galactose Metabolism；Galactosemia；Galactosemia II (GALK)；Galactosemia III；Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease；Total 28 pathways, visit the HMDB page for details